CPSA’s office will be closed from 12 p.m. on Dec. 24, 2024, through Jan. 1, 2025, reopening at 8:15 a.m. on Jan. 2, 2025. For urgent requests not related to annual renewal, please call 1-800-561-3899. For all other inquiries, including those about annual renewal, please email support@cpsa.ca . We will respond when our office reopens.
Back to All News & Events

Should we add a risk model score to MD Snapshot-Prescribing?

Back to Messenger
July Messenger 2024, Prescribing | Posted July 11, 2024
Read time: 1 minute

Tell us for a chance to win an Apple Watch

MD Snapshot-Prescribing is produced quarterly by CPSA to help physicians improve patient care. It is not intended to be punitive or a judgment on clinical practice but is designed as a tool to support informed prescribing practices. Accessible online in the Analytics section of your secure CPSA Portal, MD Snapshot-Prescribing offers trend and comparison data on antibiotic, benzodiazepine and z-drug, opioid and new opioid prescribing.

Working with our analytics team, CPSA has developed a model using machine learning methods to predict individual-level patient risk of hospitalization, emergency department visits and mortality within 30 days of an opioid prescription. The results were encouraging, and a study was published in 2022.

Based on this work, we are exploring adding an opioid risk model score to MD Snapshot-Prescribing and would appreciate feedback on whether this information would be helpful and useful to your prescribing practice. Participants who complete a short survey can enter a draw to win an Apple Watch. Responses will be summarized anonymously and will help us improve MD Snapshot-Prescribing.

Take the survey

Questions? Contact us at air.inquiries@cpsa.ab.ca.

Comments for this post are now closed. If you would like to share your feedback on this topic, please email support@cpsa.ca.